CN102669116A - Abamectin quizalofop-p-ethyl emulsifiable concentrate - Google Patents

Abamectin quizalofop-p-ethyl emulsifiable concentrate Download PDF

Info

Publication number
CN102669116A
CN102669116A CN2011100640767A CN201110064076A CN102669116A CN 102669116 A CN102669116 A CN 102669116A CN 2011100640767 A CN2011100640767 A CN 2011100640767A CN 201110064076 A CN201110064076 A CN 201110064076A CN 102669116 A CN102669116 A CN 102669116A
Authority
CN
China
Prior art keywords
ethyl
quizalotop
quizalofop
abamectin
wei
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011100640767A
Other languages
Chinese (zh)
Inventor
闫冰霜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011100640767A priority Critical patent/CN102669116A/en
Publication of CN102669116A publication Critical patent/CN102669116A/en
Pending legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention discloses an abamectin quizalofop-p-ethyl emulsifiable concentrate. The abamectin quizalofop-p-ethyl emulsifiable concentrate comprises, by mass, 0.1% to 0.9% of abamectin, 8.7% to 11.9% of quizalofop-p-ethyl, 2% to 6% of calcium dodecyl benzene sulfonate, 3% to 9% of benzene ethyl vinyl ether oxygen phenol together and 76.2% to 82.2 % of dimethylbenzene. Effective components of the abamectin quizalofop-p-ethyl emulsifiable concentrate are the abamectin and the quizalofop-p-ethyl, the abamectin, the quizalofop-p-ethyl and fillers are composited based on a certain proportion to prepare an abamectin quizalofop-p-ethyl compound pesticide, the insecticide resistance of crops is delayed, the control effect of the pesticide is improved, the advantages of various insecticides in the pesticide are developed, the cost is lowered, the labor-saving effect is remarkable, and economic benefits are improved.

Description

A Wei Quizalotop-ethyl missible oil
Technical field
The present invention relates to a kind of Recompounded pesticide, be specifically related to a kind of A Wei Quizalotop-ethyl missible oil.
Background technology
Principle according to a medicine is controlled more is called Recompounded pesticide with agricultural chemicals according to the agricultural chemicals that certain mixed proportion adopts compound compound method to be made into.Conventional pesticide is single agent, and single agent effect is single, and long-term the use, causes the crop pesticide resistance to improve constantly, and the effect of medicament is produced have a strong impact on, and the peasant often takes to increase consumption and keeps effect, has increased use cost, and environment is damaged.
Summary of the invention
Goal of the invention: the objective of the invention is in order to solve the deficiency of prior art, a kind of A Wei Quizalotop-ethyl missible oil is provided.
The technical scheme that the present invention adopts: a kind of A Wei Quizalotop-ethyl missible oil comprises following component by mass percent: AVM 0.1-0.9%, Quizalotop-ethyl 8.7-11.9%, calcium dodecyl benzene sulfonate 2-6%, phenethyl phenol polyethenoxy ether 3-9%, xylol 76.2-82.2%.
As optimization, the mass percent of said AVM is 0.5% of a said A Wei Quizalotop-ethyl missible oil.
As optimization, the mass percent of said Quizalotop-ethyl is 10.3% of a said A Wei Quizalotop-ethyl missible oil.
As optimization, the mass percent of said calcium dodecyl benzene sulfonate is 4% of a said A Wei Quizalotop-ethyl missible oil.
As optimization, the mass percent of said phenethyl phenol polyethenoxy ether is 6% of a said A Wei Quizalotop-ethyl missible oil.
As optimization, the mass percent of said xylol is 79.2% of a said A Wei Quizalotop-ethyl missible oil.
It is raw material that the present invention adopts AVM, Quizalotop-ethyl, calcium dodecyl benzene sulfonate, phenethyl phenol polyethenoxy ether, xylol, is mixed into A Wei Quizalotop-ethyl missible oil in proportion at normal temperatures.
Beneficial effect: the present invention compared with prior art, its remarkable advantage is: the active ingredient of product of the present invention is AVM and Quizalotop-ethyl, and AVM, Quizalotop-ethyl and filler are re-dubbed A Wei Quizalotop-ethyl Recompounded pesticide by a certain percentage; Delayed the pesticide resistance of crop; Improve the control efficiency of agricultural chemicals, brought into play the wherein strong point of various medicaments, reduced cost; Saving of labor's remarkable benefit has improved economic benefit.
Embodiment
Below in conjunction with specific embodiment the present invention is described further:
Embodiment 1
AVM with 0.1%, 8.7% Quizalotop-ethyl, 6% calcium dodecyl benzene sulfonate, 3% phenethyl phenol polyethenoxy ether, 82.2% xylol drop in the agitated reactor at normal temperatures that mixing and stirring can obtain described A Wei Quizalotop-ethyl missible oil, and the percentage described in the present invention is mass percent.
Embodiment 2
AVM with 0.5%, 10.3% Quizalotop-ethyl, 4% calcium dodecyl benzene sulfonate, 6% phenethyl phenol polyethenoxy ether, 79.2% xylol drop in the agitated reactor at normal temperatures, and mixing and stirring can obtain described A Wei Quizalotop-ethyl missible oil.
Embodiment 3
AVM with 0.9%, 11.9% Quizalotop-ethyl, 2% calcium dodecyl benzene sulfonate, 9% phenethyl phenol polyethenoxy ether, 76.2% xylol drop in the agitated reactor at normal temperatures, and mixing and stirring can obtain described A Wei Quizalotop-ethyl missible oil.

Claims (6)

1. A Wei Quizalotop-ethyl missible oil, it is characterized in that: it comprises following component by mass percent: AVM 0.1-0.9%, Quizalotop-ethyl 8.7-11.9%, calcium dodecyl benzene sulfonate 2-6%, phenethyl phenol polyethenoxy ether 3-9%, xylol 76.2-82.2%.
2. according to claims 1 described A Wei Quizalotop-ethyl missible oil, it is characterized in that: the mass percent of said AVM is 0.5% of a said A Wei Quizalotop-ethyl missible oil.
3. according to claims 1 described A Wei Quizalotop-ethyl missible oil, it is characterized in that: the mass percent of said Quizalotop-ethyl is 10.3% of a said A Wei Quizalotop-ethyl missible oil.
4. according to claims 1 described A Wei Quizalotop-ethyl missible oil, it is characterized in that: the mass percent of said calcium dodecyl benzene sulfonate is 4% of a said A Wei Quizalotop-ethyl missible oil.
5. according to claims 1 described A Wei Quizalotop-ethyl missible oil, it is characterized in that: the mass percent of said phenethyl phenol polyethenoxy ether is 6% of a said A Wei Quizalotop-ethyl missible oil.
6. according to claims 1 described A Wei Quizalotop-ethyl missible oil, it is characterized in that: the mass percent of said xylol is 79.2% of a said A Wei Quizalotop-ethyl missible oil.
CN2011100640767A 2011-03-16 2011-03-16 Abamectin quizalofop-p-ethyl emulsifiable concentrate Pending CN102669116A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100640767A CN102669116A (en) 2011-03-16 2011-03-16 Abamectin quizalofop-p-ethyl emulsifiable concentrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100640767A CN102669116A (en) 2011-03-16 2011-03-16 Abamectin quizalofop-p-ethyl emulsifiable concentrate

Publications (1)

Publication Number Publication Date
CN102669116A true CN102669116A (en) 2012-09-19

Family

ID=46802210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100640767A Pending CN102669116A (en) 2011-03-16 2011-03-16 Abamectin quizalofop-p-ethyl emulsifiable concentrate

Country Status (1)

Country Link
CN (1) CN102669116A (en)

Similar Documents

Publication Publication Date Title
CN102246770A (en) Oxadiazon.acetochlor missible oil
CN102246814A (en) Apholate-chlorpyrifos microemulsion
CN102669163A (en) Phoxim-pyridaben missible oil
CN102246768A (en) Olefine ketone.benazolin missible oil
CN102246782A (en) Jinggang.carbendazim suspension agent
CN102669116A (en) Abamectin quizalofop-p-ethyl emulsifiable concentrate
CN102246816A (en) Avermectin.triazophos emulsifiable concentrate
CN102669168A (en) Propyl bromide chlorpyrifos emulsifiable concentrate
CN102246764A (en) Quizalofop fomesafen missible oil
CN102246813A (en) Avermectin-chlopyrifos emulsifiable concentrate
CN102669172A (en) Apholate pyridaben emulsifiable concentrate
CN102246780A (en) Metalaxyl and propamocarb wettable powder
CN102669167A (en) Pyridaben-chlorpyrifos missible oil
CN102669107A (en) Quizalofop-ethyl-fluorine EC
CN102669095A (en) Fluroxypyr clethodim missible oil
CN102246754A (en) Fomesafen.clethodim emulsifiable concentrate
CN102246787A (en) Pyrazosulfuron and quinclorac wettable powder
CN102669106A (en) Ketene-pyridaben EC
CN102669166A (en) Imidacloprid-chlorpyrifos suspending agent
CN102246767A (en) Quizalofop-p-ethyl benazolin ethyl emulsifiable concentrate
CN102246822A (en) Prochloraz-manganese chloride complex. carbendazim wettable powder
CN102246773A (en) Abamectin and pyridaben missible oil
CN102669169A (en) Propyl bromide triazophos emulsifiable concentrate
CN102669117A (en) Abamectin and quizalofop-ethyl cream
CN102669143A (en) Imidacloprid-benazolin missible oil

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
DD01 Delivery of document by public notice

Addressee: Yan Bingshuang

Document name: Notification of Publication of the Application for Invention

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120919